Over the latest trailing 12-month period, total return cagr is +34.22%. The comparable SPY value is +20.57%. Year-to-date total return is -5.46%. Total return includes price appreciation and reinvested dividends.
Growth of $10,000 in GMED
$61,141
(6.1x return)
Invested on Aug 3, 2012
Growth of $10,000 in SPY (S&P 500)
$69,980
(7.0x return)
Invested on Aug 3, 2012
This chart illustrates the cumulative performance of a hypothetical $10,000 investment. It assumes that all dividends paid by both the stock and SPY are reinvested in additional shares on the payment date, showing the true long-term compounding impact of distributions.
YTD Total Return
-5.5%
1-Year Total Return
+34.2%
Current Dividend Yield
N/A
Compound Annual Growth Rate (CAGR) is shown below. The difference between price CAGR and total return CAGR is the compound contribution of dividends reinvested.
| Holding Period | Price CAGR | Total Return CAGR | Dividend Addition |
|---|---|---|---|
| 1 Year | +34.2% | +34.2% | N/A |
| 3 Years | +14.6% | +14.6% | N/A |
| 5 Years | +0.2% | +0.2% | N/A |
| 10 Years | +13.8% | +13.8% | N/A |
| 15 Years | N/A | N/A | N/A |
| 20 Years |
| N/A |
| N/A |
| N/A |
